San Francisco is taking one huge step towards normalizing psychedelics. In recent news, the city’s lawmakers have introduced a bill that would partially decriminalize psychedelic substances in San Francisco.
The city aside, California is one of the most willing states to conduct thorough research on psychedelic substances. This is especially true in institutes like the Translational Psychedelic Research Program and the California Institute of Integrative Studies.
But what should we expect from the new bill if it passes? Overall, the main point is that it would decrease the number of non-violent drug prosecutions in San Francisco. Secondly, provide healthcare workers and practitioners with easier access to psychedelics for research and therapeutic use.
In terms of what drugs are being decriminalized, the bill’s authors noted the following in a statement;
“Any investigation, detention, arrest, or prosecution arising out of alleged violations of state and federal law regarding the use of Entheogenic Plants listed on the Federally Controlled Substances Schedule 1 list.”
So, it’s not entirely decriminalizing drugs but preventing the law from taking action on individuals who choose to use them.
Furthermore, the bill stipulates that only natural psychedelic substances will fall under the decriminalization bill. The bill is titled “Supporting Entheogenic Plant Practices,” so it’s more likely that the bill was introduced to help spread access and awareness of psychedelics and their healing benefits.
If San Francisco were to pass the bill, it would put them beside Oakland as the second Californian city to decriminalize psychedelic drugs. Hopefully, it would prompt more cities and states to consider the benefits of what drug decriminalization can do for them.
The bill was introduced on July 26 by Supervisors Dean Preston and cosponsor Supervisor Hillary Ronen. However, the state senate is in recess until September 1, so we’ll have to wait until the end of the month to hear if the decriminalization bill was successful.
enter your email below to get insider updates delivered straight to your inbox.